Trials / Completed
CompletedNCT00694954
Capsule Endoscopy vs Standard of Care for Obscure Intestinal Bleeding
A Randomized Controlled Trial of Capsule Endoscopy vs Standard Care in Patients With Iron Deficiency Anemia With Suspected Obscure / Occult Gastrointestinal Bleeding
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- University of Calgary · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The role of capsule endoscopy (CE) in patients with obscure / occult gastrointestinal (GI) bleeding remains unclear. This pragmatic randomized controlled trial is designed to determine the diagnostic yield and clinical outcomes of patients with obscure GI bleeding who receive CE compared to those who receive usual standard care.
Detailed description
Patients with iron deficiency anemia from suspected occult GI bleeding will be randomized to receive CE or usual standard care following a negative gastroscopy and colonoscopy. Our primary outcome measure (diagnostic yield) and secondary outcome measures (noted below) will be determined after one year of followup. Patients with have a minimum of one year of clinical followup. Direct health care costs in each arm of the study will be determined after a minimum of two years of followup. An economic evaluation based on the results of the clinical trial is also planned.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Diagnostic Test - Given Imaging Pillcam | Procedure performed once only after randomization. If procedure is incomplete due to a number of variables, procedure may possibly need to be repeated. Diagnostic possibilities: normal exam, active bleeding, potential source of bleeding (angiodysplasia, ulcer, tumor) |
| OTHER | Diagnostics | Any other diagnostic tests (if not already performed) that the referring or attending physician deems necessary aside from Wireless Capsule Endoscopy. |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2015-12-01
- Completion
- 2016-07-01
- First posted
- 2008-06-11
- Last updated
- 2017-12-05
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00694954. Inclusion in this directory is not an endorsement.